BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $294,000 | -6.7% | 3,658 | -6.6% | 0.27% | -7.3% |
| Q2 2021 | $315,000 | -13.7% | 3,918 | -9.5% | 0.29% | -18.9% |
| Q1 2021 | $365,000 | +5.2% | 4,328 | 0.0% | 0.35% | +6.9% |
| Q4 2020 | $347,000 | -6.2% | 4,328 | -6.0% | 0.33% | -12.0% |
| Q3 2020 | $370,000 | -6.6% | 4,603 | 0.0% | 0.38% | -16.3% |
| Q2 2020 | $396,000 | +20.7% | 4,603 | +14.0% | 0.45% | +4.7% |
| Q1 2020 | $328,000 | +7.5% | 4,038 | +10.8% | 0.43% | +32.4% |
| Q4 2019 | $305,000 | -4.4% | 3,643 | 0.0% | 0.32% | -20.8% |
| Q3 2019 | $319,000 | -37.6% | 3,643 | -41.6% | 0.41% | -30.0% |
| Q2 2019 | $511,000 | +10.4% | 6,243 | +9.7% | 0.58% | +9.2% |
| Q1 2019 | $463,000 | +58.6% | 5,693 | +28.4% | 0.54% | +48.6% |
| Q4 2018 | $292,000 | -5.5% | 4,433 | +10.6% | 0.36% | +11.5% |
| Q3 2018 | $309,000 | +4.4% | 4,008 | 0.0% | 0.32% | -0.9% |
| Q2 2018 | $296,000 | -90.1% | 4,008 | -90.7% | 0.33% | -50.1% |
| Q2 2013 | $2,977,000 | – | 42,973 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |